1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ProQR Therapeutics NV (PRQR)
  7. Quote

PRQR

ProQR Therapeutics NV Stock Price

7.88
0.07 (0.9%)
Upgrade to Real-Time
Afterhours (Closed)
7.88

Low
3.40

52 Week Range

High
9.46

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
ProQR Therapeutics NV PRQR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.07 0.9% 7.88 20:00:00
Open Price Low Price High Price Close Price Prev Close
7.88 7.70 7.99 7.88 7.81
Bid Price Ask Price Spread News
7.25 8.25 1.00 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,159 397,852 $ 7.83 $ 3,115,986 - 3.40 - 9.46
Last Trade Time Type Quantity Stock Price Currency
16:00:05 formt 645 $ 7.88 USD

Period:

Draw Mode:

ProQR Therapeutics NV Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 528.50M 67.07M 57.83M $ - $ - -1.13 -6.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

ProQR Therapeutics NV News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PRQR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.538.057.477.80328,4270.354.65%
1 Month8.099.097.257.90691,493-0.21-2.6%
3 Months5.459.095.037.27799,3162.4344.59%
6 Months6.339.095.036.85674,4681.5524.49%
1 Year4.559.463.407.551,317,3453.3373.19%
3 Years17.3924.003.408.25584,309-9.51-54.69%
5 Years6.3524.002.758.48401,9601.5324.09%

ProQR Therapeutics NV Description

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.


Your Recent History
NASDAQ
PRQR
ProQR Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.